|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Divisions of Neurology (D.M.A., D.Z., S.S., R.A.W.) and Neurosurgery (C.H., M.H., A.M.L.), Krembil Neuroscience Centre, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
Address correspondence and reprint requests to Dr. Richard A. Wennberg, Toronto Western Hospital, 399 Bathurst Street, 5W444, Toronto, ON, Canada M5T 2S8; e-mail: r.wennberg{at}utoronto.ca
The authors describe long-term follow-up (mean, 5 years) in patients with anterior (AN) (n = 6) or centromedian (n = 2) thalamic deep brain stimulation (DBS) for epilepsy. Five patients (all AN) had
50% seizure reduction, although benefit was delayed in two until years 5 to 6, after changes in antiepileptic drugs. DBS electrode implantation in AN patients was followed by seizure reduction 1 to 3 months before active stimulation, raising the possibility of a beneficial microthalamotomy effect.
Editorial, see page 1468
See also page 1490
This article was previously published in electronic format as an Expedited E-Pub on March 15, 2006, at www.neurology.org.
Disclosure: Dr. Lozano and Dr. Wennberg are consultants for Medtronic, Inc.
Received September 1, 2005. Accepted in final form January 3, 2006.
This article has been cited by other articles:
![]() |
R. P. Lesser and W. H. Theodore If not pharmacology, maybe physics Neurology, May 23, 2006; 66(10): 1468 - 1469. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |